Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACP-044 in osteoarthritis knee pain
NCT05008835Phase 2Terminated
- Sponsor
- Acadia Pharmaceuticals
- Start
- Jul 2021
- Primary completion
- Oct 2022
- Countries
- 1
01
Overview
A Phase 2 trial of CT-044 in osteoarthritis (OA), sponsored by Acadia Pharmaceuticals. Started Jul 2021; status: terminated.
02
Drugs
CT-044
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT05008835.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05008835.